WHO approves China’s SINOVAC Covid vaccine for emergency use

China’s SINOVAC Covid vaccine has been approved by the World Health Organization for Emergency Use Listing, EUL.

Daily Current Affairs Quiz 2021

WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement.

It opens the door for the jab to be used in the COVAX programme, which aims to ensure fair access to vaccines. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac.

The Sinovac-CoronaVac product is an inactivated vaccine (The disease-carrying virus or bacterium, or one very similar to it, is inactivated or killed using chemicals, heat or radiation).

Its easy storage requirements make it very manageable and particularly suitable for low-resource settings.